cmAngio® vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by Mycardium AI Limited

AI Verdict

Tool A (cmAngio®) focuses on detecting Breast Arterial Calcifications on mammograms to assess cardiovascular risk, leveraging existing women's health screenings. Tool B (1CMR Pro) specializes in enhancing the precision and speed of cardiac MRI reporting for detailed analysis of heart structure and function. While both contribute to cardiovascular health insights through AI in medical imaging, they utilize distinct modalities and address different stages or types of assessment.

Choose cmAngio® if…

Choose cmAngio® if your institution aims to integrate opportunistic cardiovascular risk assessment into routine mammography screenings. This tool is ideal for leveraging existing breast imaging workflows to identify Breast Arterial Calcifications (BAC), providing early insights into a woman's cardiovascular health without requiring additional procedures or radiation. It's particularly beneficial for enhancing preventative care strategies by connecting breast health with broader cardiovascular risk assessment.

View cmAngio® →

Choose 1CMR Pro if…

Choose 1CMR Pro if your cardiology or radiology department requires highly precise, consistent, and efficient analysis of Cardiac MRI studies. This AI-enhanced software is best suited for environments where automated volumetric and functional measurements are critical for accurate diagnosis, treatment planning, and research, offering significantly higher precision and reproducibility compared to manual analysis. It streamlines cardiac MRI reporting by automating complex measurements while ensuring clinician oversight with transparent and editable contours.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® 1CMR Pro
Pricing Paid, out-of-pocket Contact for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® 1CMR Pro
Product Name cmAngiou00ae 1CMR Pro
Primary Function/Detection Detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis.
Target Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Radiology
Key Technology/Method AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard. AI-enhanced Cardiac MRI Reporting; Automated volumetric and functional measurements; Convolutional neural networks trained on extensive datasets (700,000 cine images, 60,000 expert segmentations).
Data Processing Location Not specified Local data processing (no patient data transmitted beyond institution).

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae is FDA-cleared AI software designed for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. In contrast, 1CMR Pro is an FDA 510(k) cleared and CE Class IIB cleared AI-enhanced Cardiac MRI reporting software that delivers more precise measurements for faster and more consistent cardiac MRI analysis.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. 1CMR Pro is specifically designed for AI-enhanced reporting of Cardiac MRI studies, compatible with 1.5T and 3T CMR acquisitions.
cmAngiou00ae is cybersecure and HIPAA-compliant, and is inferred to be cloud-based. 1CMR Pro is deployed on-premise, processing data locally via a secure web-based platform with no patient data transmitted beyond the institution, and is likely HIPAA compliant due to local data processing and ISO 27001 certification.
cmAngiou00ae enables BAC identification and reporting without additional radiation or procedures, and offers quick and easy installation. 1CMR Pro provides automated volumetric and functional measurements, achieving up to 40% higher precision than manual analysis for cardiac MRI reporting.
cmAngiou00ae by CureMetrix is FDA-cleared AI software. 1CMR Pro by Mycardium AI is both FDA 510(k) cleared and CE Class IIB cleared.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties. 1CMR Pro primarily targets Cardiology and Radiology specialties.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.